Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Putting the Pieces Together: Cervical Dystonia Diagnosis, Comorbidities, and Treatment

Chapters
1234

Cervical Dystonia and Chronic Migraine Comorbidity: Background, Diagnosis, and Treatment

OnabotulinumtoxinA in Cervical Dystonia

Botulinum Toxins: Dosing and Duration of Treatment

OnabotulinumtoxinA: Manufacturing, Non-interchangeability, and Non-Medical Switching

Please see Important Safety Information within the video.

Please see full Prescribing Information including Boxed Warning and Medication Guide here.

Clinical Perspectives presented by:
Mitchell Brin, MD, FAAN, FANA, FAHS

Mitchell Brin, MD, FAAN, FANA, FAHS

Senior Vice President, R&D

Chief Scientific Officer, Neurotoxins

Clinical Professor of Neurology,

University of California, Irvine

Jack W. Tsao, MD, DPhil

Jack W. Tsao, MD, DPhil

Edwin H. Kolodny, MD Professor of Neurology

Department of Neurology

NYU Grossman School of Medicine

New York, NY

Program Objective
objective icon

Learn how onabotulinumtoxinA is made, why botulinum toxins are non-interchangeable and why it matters.

This site is intended for U.S. Healthcare Professionals only. Use of and access to this site are subject to the Terms of Use and Privacy Policy.
The information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider.
All decisions regarding patient care must be made by a healthcare provider considering the unique characteristics of the patient.

Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A. BONT-US-00017-MC. V2, May 2024.